Copley Equity invests in AeroMed Group

Copley Equity Partners (Copley Equity), a private equity firm and family office headquartered in Boston, Massachusetts has completed a growth investment in AeroMed Group (AeroMed) to facilitate the company’s acquisition of etaGLOBAL. 

Terms of the transaction have not been disclosed.

AeroMed, based in Charlotte, NC, will utilise Copley’s investment to assist in the company’s strategy to build a market-leading supply chain solutions provider to the Aerospace and Defense industries. Copley’s funding supported AeroMed’s acquisition of etaGLOBAL, a Palestine, TX based distributor of class-c parts to customers operating in the Aerospace & Defense sectors. As part of the transaction, Copley Equity representatives Peter Trovato, Sean Sullivan, and Dan Turk will participate on the AeroMed Board of Directors.

Bob Spence, President and CEO of AeroMed, says: “etaGLOBAL is a well-respected leader in the fragmented class-c part aerospace distribution market with over 40 years of operating history and long-standing, blue-chip customer relationships - all characteristics that AeroMed is seeking in other leading A&D supply chain management providers. We are excited to support etaGLOBAL in continuing to deliver exceptional customer service while also expanding the company’s product and service offering. Furthermore, AeroMed is excited to partner with Copley Equity Partners which brings a strong track record of helping lower middle-market companies expand.”

Peter Trovato, Managing Director of Copley Equity Partners, says: “Copley is thrilled to partner with the AeroMed and etaGLOBAL team. Both the AeroMed and etaGLOBAL management teams have demonstrated a commitment to exceptional customer service and long history of supporting top companies in the Aerospace & Defense sector. We are excited to help further build the AeroMed platform and support the company’s organic growth strategy along with accelerating their efforts to identify, and integrate, additional leading businesses under the AeroMed umbrella."

Author Profile